Sernova Corp. is a Canada-based health sciences company focused on commercializing medical technologies. The Company is developing a platform technology for a range of disease indications, starting with a treatment for insulin-dependent diabetes, using the Cell Pouch System, a medical device for transplantation and long-term support of therapeutic cells, and its Sertolin cell technology, which provides local immune protection of therapeutic cells. Cell Pouch is a subcutaneous implantable medical device, to solve a range of issues arising from portal vein delivery. The Cell Pouch provides a natural setting for the islets where they reside in a tissue matrix with micro-vessels growing adjacent to and into the islets, which are then nourished naturally. It is evaluating the Cell Pouch System, in a tiered product development approach, including testing autograft islets (i.e., an individual�s own islets) placed in the Cell Pouch in patients with chronic pancreatitis.